AMOSO Funding Recipients (Winter 2024)
Richard Kim MD - "Pharmacogenomics-based Precision Medicine for Preventing Severe Toxicity to 5-Fluorouracil based Chemotherapy: Beyond Simple Genotype Testing."
Anthony C. Nichols MD - "Defining the transcriptomic, cellular, and genetic architecture of idiopathic subglottic stenosis."
Armen Parsyan MD - "Spatial Omics for Novel Prognostic and Neoadjuvant Chemotherapy Response Biomarkers Discovery in Triple-Negative Breast Cancer."
